Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1963 1
1972 1
1976 2
1980 1
1982 1
1985 2
1986 3
1987 3
1988 1
1989 3
1991 2
1992 3
1995 3
1996 3
1997 2
1998 7
1999 10
2000 3
2001 7
2002 9
2003 11
2004 21
2005 24
2006 26
2007 33
2008 36
2009 38
2010 29
2011 27
2012 42
2013 40
2014 52
2015 39
2016 46
2017 48
2018 51
2019 40
2020 43
2021 46
Text availability
Article attribute
Article type
Publication date

Search Results

668 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Kuitto
Page 1
Current trends in sport injury prevention.
Emery CA, Pasanen K. Emery CA, et al. Best Pract Res Clin Rheumatol. 2019 Feb;33(1):3-15. doi: 10.1016/j.berh.2019.02.009. Epub 2019 Feb 23. Best Pract Res Clin Rheumatol. 2019. PMID: 31431273 Review.
African swine fever - A review of current knowledge.
Blome S, Franzke K, Beer M. Blome S, et al. Virus Res. 2020 Oct 2;287:198099. doi: 10.1016/j.virusres.2020.198099. Epub 2020 Aug 2. Virus Res. 2020. PMID: 32755631 Free article. Review.
Patent spotlight: small-molecule lysine acetyltransferase inhibitors (KATi).
Brown JA. Brown JA. Pharm Pat Anal. 2020 Jan;9(1):17-28. doi: 10.4155/ppa-2019-0025. Epub 2020 Feb 3. Pharm Pat Anal. 2020. PMID: 32008421
Here, the patent landscape surrounding lysine acetyltransferase inhibitors (KATi or HATi), with a focus on small-molecule compounds, is outlined and assessed. Overall, the 36 KATi-specific patents found were categorized into two distinct groups: specific small-molec …
Here, the patent landscape surrounding lysine acetyltransferase inhibitors (KATi or HATi), with a focus on small-molecule compounds, …
Targeting cancer using KAT inhibitors to mimic lethal knockouts.
Brown JA, Bourke E, Eriksson LA, Kerin MJ. Brown JA, et al. Biochem Soc Trans. 2016 Aug 15;44(4):979-86. doi: 10.1042/BST20160081. Biochem Soc Trans. 2016. PMID: 27528742 Free PMC article. Review.
We investigate the different methods of KATi production or discovery, their mechanisms and their validation models. ...This approach, combined with the rapidly developing interest in KATi, suggests that KATi have a bright future for providing truly personaliz …
We investigate the different methods of KATi production or discovery, their mechanisms and their validation models. ...This approach, …
Lysine Acetyltransferase Inhibitors From Natural Sources.
Fiorentino F, Mai A, Rotili D. Fiorentino F, et al. Front Pharmacol. 2020 Aug 12;11:1243. doi: 10.3389/fphar.2020.01243. eCollection 2020. Front Pharmacol. 2020. PMID: 32903408 Free PMC article. Review.
To date, only a few KATi have proven to be potential drug candidates, and there is still a keen interest in designing molecules showing drug-like properties from both pharmacodynamics and pharmacokinetics point of view. Increasing literature evidence has been highlighting …
To date, only a few KATi have proven to be potential drug candidates, and there is still a keen interest in designing molecules showi …
Lysine acetyltransferase inhibitors: structure-activity relationships and potential therapeutic implications.
Fiorentino F, Mai A, Rotili D. Fiorentino F, et al. Future Med Chem. 2018 May 1;10(9):1067-1091. doi: 10.4155/fmc-2017-0244. Epub 2018 Apr 20. Future Med Chem. 2018. PMID: 29676588 Review.
The dysregulation of this enzyme activity is implicated in many human pathologies such as cancer, neurological and inflammatory disorders. Many lysine acetyltransferase inhibitors (KATi) have been developed so far, but there is still the need for new, more potent, metaboli …
The dysregulation of this enzyme activity is implicated in many human pathologies such as cancer, neurological and inflammatory disorders. M …
Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs.
Mosca M, Croci C, Mostardini M, Breton J, Malyszko J, Avanzi N, Toma S, Benatti L, Gatti S. Mosca M, et al. Biochim Biophys Acta. 2003 Jul 9;1628(1):1-10. doi: 10.1016/s0167-4781(03)00071-x. Biochim Biophys Acta. 2003. PMID: 12850267
One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). ...Both findings correlate with the predicted accessibility of the ribosomal b …
One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transami …
Kynurenine aminotransferase I (KATI) isoform gene expression in the rat brain: an in situ hybridization study.
Tamburin M, Mostardini M, Benatti L. Tamburin M, et al. Neuroreport. 1999 Jan 18;10(1):61-5. doi: 10.1097/00001756-199901180-00012. Neuroreport. 1999. PMID: 10094134
Kynurenine aminotransferase I (KATI) converts kynurenine into kynurenic acid (KYNA), a broadspectrum antagonist at ionotropic excitatory amino acid receptors. ...Neuronal expression of KATI mRNA was further confirmed by RT-PCR and in a model of transient cerebral is …
Kynurenine aminotransferase I (KATI) converts kynurenine into kynurenic acid (KYNA), a broadspectrum antagonist at ionotropic excitat …
668 results